Uniquity Bio launches to focus on immunology and inflammation

Blackstone has committed $300m to advance solrikitug for multiple indications.

Related Keywords

Brian Lortie ,Uniquity Bio ,Blackstone Life Sciences ,Drug Administration ,Pharmaceutical Technology ,